SCHEMBL20054130

SCHEMBL20054130

C=C(C)CC1CCC(F)(F)CC1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.32
APLNR P35414 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26511162 0.79 NAAA (0.31) EPHX2
SCHEMBL15116404 0.78 EPHX2 (0.39) EPHX2APLNR
SCHEMBL22916588 0.77 APLNR (0.48) APLNR
SCHEMBL26496857 0.75
SCHEMBL20804202 0.75
SCHEMBL7003406 0.74
SCHEMBL3069324 0.72 EPHX1 (0.40) EPHX2
SCHEMBL14354172 0.72 EPHX1 (0.40) EPHX2
SCHEMBL940485 0.71 SLC6A1 (0.42)
SCHEMBL23990246 0.71 TDP1 (0.35) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 EP disclosed